Thursday,
December 4 , 2025

Endocrinologists, general and internal medicine specialists, hepatologists, advanced practice providers (APPs), pharmacists, and cardiologists who provide care to patients with obesity and associated comorbidities, including MASLD and MASH, CVD, T2D, and CKD.

After completing this activity, the participant should be better able to:

• Outline the pathophysiological processes leading to the development of obesity and associated comorbidities including metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction associated steatohepatitis (MASH)
• Implement evidence-based best practices for screening for and diagnosis of MASLD and MASH in patients with obesity
• Evaluate new treatment approaches for obesity and MASLD/MASH

• Welcome and Introduction
• Pathophysiology of Obesity: Understanding Mechanisms That Modulate Body Weight and Lead to Obesity-Associated Comorbidities
• The Role of the Liver in Metabolic Disease in Patients with Obesity
• Emerging Options for Treatment of MASLD/MASH in Patients with Obesity
• Conclusions and Q+A with Expert Faculty

This activity is provided by MLI, in collaboration with TMIOA/MEEF

Accreditation, Support and Credit 

In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.

PA

Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

Pharmacy

Medical Learning Institute Inc designates this knowledge/application-based* continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA0007322-0000-25-XXX-L01-P*

For Pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP website: https://nabp.pharmacy/

*TBA if knowledge- or application-based CE. UAN to be updated pending pharmacist designation confirmed.

Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.